Bosh sahifaPLX • NYSEAMERICAN
add
Protalix Biotherapeutics Inc
Yopilish kursi
1,79 $
Kunlik diapazon
1,73 $ - 1,80 $
Yillik diapazon
1,32 $ - 3,10 $
Bozor kapitalizatsiyasi
142,75 mln USD
Oʻrtacha hajm
588,60 ming
Narx/foyda
38,44
Dividend daromadliligi
-
Bozor yangiliklari
Stockhouse
1 kun oldin
the Bell: TSX Index slumps into Christmas holiday | 2025-12-24 | Investing News
0,18%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 17,85 mln | -0,60% |
Joriy xarajat | 7,40 mln | 32,24% |
Sof foyda | 2,36 mln | -27,22% |
Sof foyda marjasi | 13,19 | -26,80% |
Har bir ulushga tushum | — | — |
EBITDA | 2,50 mln | -42,06% |
Amaldagi soliq stavkasi | -5,18% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 29,37 mln | 7,15% |
Jami aktivlari | 82,26 mln | 33,63% |
Jami passivlari | 29,36 mln | 0,79% |
Umumiy kapital | 52,91 mln | — |
Tarqatilgan aksiyalar | 80,42 mln | — |
Narxi/balansdagi bahosi | 2,70 | — |
Aktivlardan daromad | 6,63% | — |
Kapitaldan daromad | 9,16% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 2,36 mln | -27,22% |
Operatsiyalardan naqd pul | -3,73 mln | -190,91% |
Sarmoyadan naqd pul | -504,00 ming | -102,48% |
Moliyadan naqd pul | 0,00 | 100,00% |
Naqd pulning sof oʻzgarishi | -4,25 mln | -205,94% |
Boʻsh pul | -6,02 mln | -671,68% |
Haqida
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
CEO
Tashkil etilgan
1993
Bosh ofis
Sayt
Xodimlar soni
213
